St. Jude Augments AF Division With $47 Mil. Irvine Biomedical Purchase

St. Jude will evaluate whether to pursue an atrial fibrillation indication for Irvine Biomedical, Inc.'s Therapy, Dual 8 and Cooled-Tip ablation catheters

More from Archive

More from Medtech Insight